Pierre Thibault

Récents

• Novel tumor-specific antigens for acute myeloid leukemia (aml) and uses thereof
• BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
• Proteogenomic-based method for identifying tumor-specific antigens
• Transposable elements regulate thymus development and function
• Unmutated tumor antigens are abundant and contribute to tumor control in melanoma
• Identification of Novel Cell Surface Therapeutic Targets for KMT2A-Rearranged Acute Myeloid Leukemia
• Induced pluripotent stem cells display a distinct set of MHC I-associated peptides shared by human cancers
• Proteogenomics and Differential Ion Mobility Enable the Exploration of the Mutational Landscape in Colon Cancer Cells
• Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes
• CAMAP - Artificial neural networks unveil the role of codon arrangement in modulating MHC-I peptides presentation
• Most non-canonical proteins uniquely populate the proteome or immunopeptidome
• Novel tumor-specific antigens for ovarian cancer and uses thereof
• MAPDP - A Cloud-Based Computational Platform for Immunopeptidomics Analyses
• Proteogenomics Uncovers a Vast Repertoire of Shared Tumor-Specific Antigens in Ovarian Cancer
• Surface proteomics reveals novel potentiel AML antigens for immunitherapeutic targeting
• Widespread and tissue-specific expression of endogenous retroelements in human somatic tissues
• Method for identifying novel minor histocompatibility antigens
• Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
• Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of Mitochondrial Vulnerability in Acute Myeloid Leukemia
• Noncoding regions are the main source of targetable tumor-specific antigens